Lipoxamycin hemisulfate is primarily used in research settings as an antibiotic agent due to its ability to inhibit bacterial growth. It is particularly studied for its potential in combating Gram-positive bacteria, making it a candidate for developing new antibacterial therapies. In laboratory studies, it has shown efficacy in targeting specific bacterial pathways, which could lead to the development of novel treatments for resistant bacterial infections. Additionally, its mechanism of action is of interest in understanding bacterial resistance and exploring ways to overcome it. Researchers also investigate its potential synergistic effects with other antibiotics to enhance therapeutic outcomes.